{"database": "lobbying", "table": "lobbying_activities", "rows": [[1765028, "7796a97d-14e8-4b75-8a62-c7064193ad4d", "Q4", "MEHLMAN CONSULTING, INC.", 284950, "VALEANT PHARMACEUTICAL NORTH AMERICA LLC", 2015, "fourth_quarter", "LBR", "Corporate structure.", "HOUSE OF REPRESENTATIVES,SENATE", 60000, null, 0, 0, "2016-01-12T14:08:13.790000-05:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1765028"], "units": {}, "query_ms": 4.148380015976727, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}